Upper Gastrointestinal Tract Phenotype of Crohn's Disease is Associated with Early Surgery and Further Hospitalization
Overview
Authors
Affiliations
Background: According to the Montreal Classification, upper gastrointestinal tract phenotype L4 is uncommon in Caucasian patients with Crohn's disease (CD) but carries excess risk of recurrence. We studied the clinical course of CD in Chinese patients presenting with the L4 phenotype and factors predicting its occurrence upon longitudinal follow-up.
Methods: This prospective cohort study included 132 Chinese CD patients (median age at diagnosis, 30.0 years, range: 14.0-77.0 years) who were followed for 770 person-years. Demographic data including disease behavior and location, details of surgery, and hospitalization were collected. The Kaplan-Meier method was used to estimate the probabilities of further hospitalization and major surgery followed by Cox proportional hazards regression to determine if clinical variables independently predicted the endpoints.
Results: The L4 phenotype was found in 30 (22.7%) patients at presentation. There were significantly more stricturing (46.7% versus 18.6%) and penetrating (30.0% versus 3.9%) phenotypes in the L4 group than in the non-L4 group (P < 0.0001). The 3-year cumulative probability of further hospitalization was 86.9% (95% confidence interval [CI]: 73.8%-100.0%) in the L4 group as compared with 49.3% (95% CI: 39.3%-59.3%) in the non-L4 group (log-rank test, P < 0.0001). The L4 phenotype independently predicted further hospitalization (adjusted hazards ratio [HR]: 2.1; 95% CI: 1.3-3.5). The cumulative probability of major surgery was significantly higher in the L4 than in the non-L4 group (P < 0.0001). Eighteen (17.6%) patients developed the L4 phenotype on follow-up and the stricturing phenotype predicted its occurrence (adjusted HR: 5.5; 95% CI: 2.2-14.0).
Conclusions: Chinese CD patients more often had the L4 phenotype, which predicted the need of subsequent hospitalization.
Hsu W, Chen C, Kuo C, Tsou Y, Yeh P, Lai M Dig Dis Sci. 2024; 69(9):3382-3391.
PMID: 39090445 DOI: 10.1007/s10620-024-08577-5.
Global geoepidemiology of gastrointestinal surgery rates in Crohn's disease.
Weissman S, Aziz M, Bangolo A, Nagesh V, Aung H, Mathew M World J Gastrointest Surg. 2024; 16(6):1835-1844.
PMID: 38983343 PMC: 11230035. DOI: 10.4240/wjgs.v16.i6.1835.
Surgical management of duodenal crohn's disease.
McKenna N, Bews K, Mirande M, Abarca Rendon F, Ofshteyn A, Peponis T Langenbecks Arch Surg. 2024; 409(1):132.
PMID: 38639899 DOI: 10.1007/s00423-024-03324-w.
Personalized Treatment for Crohn's Disease: Current Approaches and Future Directions.
Clinton J, Cross R Clin Exp Gastroenterol. 2023; 16:249-276.
PMID: 38111516 PMC: 10726957. DOI: 10.2147/CEG.S360248.
Ogasawara K, Hiraga H, Sasaki Y, Hiraga N, Higuchi N, Hasui K Diagnostics (Basel). 2023; 13(23).
PMID: 38066829 PMC: 10706147. DOI: 10.3390/diagnostics13233587.